Related Experiment Video
Updated: Feb 26, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetics of paediatric cardiomyopathies
1Departments of Pediatrics and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Genetic testing is rapidly advancing the understanding and treatment of pediatric cardiomyopathy. This progress allows for targeted therapies based on the specific genetic cause of the condition.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Pediatric cardiomyopathy is a rare, genetically influenced heart condition.
- Understanding the genetic underpinnings is crucial for effective management.
Purpose of the Study:
- To review current genetic findings in pediatric cardiomyopathy.
- To discuss advancements in genetic management and therapy.
Main Methods:
- Analysis of clinical genetic testing data.
- Review of large population genetic variation datasets.
- Examination of transcriptome and epigenome studies.
Main Results:
- Rapid identification of novel genetic causes for cardiomyopathy.
- Refined understanding of rare genetic variation significance.
- Emerging targeted therapies for specific genetic syndromes (e.g., Pompe, Noonan).
Conclusions:
- Genetic insights are transforming pediatric cardiomyopathy care.
- Targeted management and therapy based on genetic findings are becoming a reality.
- Advanced approaches like genome editing show future promise.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Incomplete Dominance
Cardiomyopathy II: Dilated Cardiomyopathy
Animal Mitochondrial Genetics
Cardiomyopathy IV: Restrictive Cardiomyopathy

